We read with interest the article by Farad et al titled "Thyroid surgery and obesity: cohort study of surgical out comes and local specific complications"1. We congratulate the authors on dealing with an issue pertinent to the present day endocrine surgeon, who has to deal with the epidemic of obesity combined with endocrine problems. We also agree with the authors that obesity poses perioperative, intra operative and post-operative risk for complications. The endocrine surgeon should have a clear road map in the form of proper preoperative planning with counseling to avoid complications.
from #Medicine-SfakianakisAlexandros via o.lakala70 on Inoreader https://ift.tt/2zWtkQU
via IFTTT
Πέμπτη 13 Δεκεμβρίου 2018
Letter to editor: “Thyroid surgery and obesity: cohort study of surgical out comes and local specific complications”
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
This case report outlines the possibility of accelerated tooth movement with the combination of microosteoperforation and mini-screws. A 14-...
-
by Rebekah L. Rogers, Ling Shao, Kevin R. Thornton One common hypothesis to explain the impacts of tandem duplications is that whole gene ...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2juls25 via IFTTT
-
by Qi Quan, Lei Hong, Biao Chang, Ruoxi Liu, Yun Zhu, Jiang Peng, Qing Zhao, Shibi Lu Purpose The purpose of this study was to simulate and...
-
A critical step in cellular-trafficking pathways is the budding of membranes by protein coats, which recent experiments have demonstrated ca...
-
by Mark A. Valasek, Irene Thung, Esha Gollapalle, Alexey A. Hodkoff, Kaitlyn J. Kelly, Joel M. Baumgartner, Vera Vavinskaya, Grace Y. Lin, A...
-
The secondary channel (SC) of multisubunit RNA polymerases (RNAPs) allows access to the active site and is a nexus for the regulation of tra...
-
by Hellen Houlleberghs, Anne Goverde, Jarnick Lusseveld, Marleen Dekker, Marco J. Bruno, Fred H. Menko, Arjen R. Mensenkamp, Manon C. W. Sp...
-
A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor British Journal of Canc...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου